Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objective To characterize large adrenal tumors (≥4 cm in diameter) and to identify features associated with malignancy. Patients and Methods We investigated the clinical, biochemical, and imaging characteristics in a large retrospective single-center cohort of patients with adrenal tumors of 4 cm or more in diameter during the period of January 1, 2000, through December 31, 2014. Results Of 4085 patients with adrenal tumors, 705 (17%) had adrenal masses measuring 4 cm or more in diameter; of these, 373 (53%) were women, with a median age of 59 years (range, 18-91 years) and median tumor size of 5.2 cm (range, 4.0-24.4 cm). Underlying diagnoses were adrenocortical adenomas (n=216 [31%]), pheochromocytomas (n=158 [22%]), other benign adrenal tumors (n=116 [16%]), adrenocortical carcinomas (n=88 [13%]), and other malignant tumors (n=127 [18%]). Compared with benign tumors, malignant tumors were less frequently diagnosed incidentally (45.5% vs 86.7%), were larger (7 cm [range, 4-24.4 cm] vs 5 cm [range, 4-20 cm]), and had higher unenhanced computed tomographic (CT) attenuation (34.5 Hounsfield units [HU] [range, 14.1-75.5 HU] vs 11.5 HU [range, −110 to 71.3 HU]; P <.001). On multivariate analysis, older age at diagnosis, male sex, nonincidental mode of discovery, larger tumor size, and higher unenhanced CT attenuation were all found to be statistically significant predictors of malignancy. Conclusion The prevalence of malignancy in patients with adrenal tumors of 4 cm or more in diameter was 31%. Older age, male sex, nonincidental mode of discovery, larger tumor size, and higher unenhanced CT attenuation were associated with an increased risk for malignancy. Clinical context should guide management in patients with adrenal tumors of 4 cm or more in diameter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925 · cited 2×
“Right 81 (38) 48 (40) 33 (34) Left 96 (44) 55 (47) 41 (42) Bilateral 39 (18) 15 (13) 24 (24)”
Self-citationPheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Self-citationThe diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“Age at diagnosis (y), median (range) 55 (18-87) 64 (18-91) <.”
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 3×
“Incidental 472 (67) 86 (54) 184 (85) 104 (90) 37 (42) 61 (48) Hormone excess 107 (15) 62 (39) 18 (8) 0 (0) 27 (31) 0 (0) Cancer staging 61 (9) 3 (2) 6 (3) 3 (3) 5 (6) 48 (38) Mass effect 51 (7) 6 (4) 6 (3) 9 (7) 18 (20) 12 (9) B symptoms 14 (2) 1 (1) 2 (1) 0 (0) 1 (1) 6 (5)”
Self-citationPrevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Song, J. H., Chaudhry, F. S., & Mayo-Smith, W. W. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2799 · Cited by 579
Zeiger, M. A., Thompson, G. B., Duh, Q.-Y., Hamrahian, A. H., Angelos, P., Elaraj, D., Fishman, E., Kharlip, J., Zeiger, M. A., Thompson, G. B., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s1.1 · Cited by 499
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458 · cited 1×
“Age at diagnosis (y), median (range) 55 (18-87) 64 (18-91) <.”
Self-citationAngeli, A., Osella, G., Ali, A., & Terzolo, M. (1997) · Hormone Research · doi:10.1159/000185477 · Cited by 259 · cited 2×
“Incidental 472 (67) 86 (54) 184 (85) 104 (90) 37 (42) 61 (48) Hormone excess 107 (15) 62 (39) 18 (8) 0 (0) 27 (31) 0 (0) Cancer staging 61 (9) 3 (2) 6 (3) 3 (3) 5 (6) 48 (38) Mass effect 51 (7) 6 (4) 6 (3) 9 (7) 18 (20) 12 (9) B symptoms 14 (2) 1 (1) 2 (1) 0 (0) 1 (1) 6 (5)”
Bancos, I., Tamhane, S., Shah, M., Delivanis, D. A., Alahdab, F., Arlt, W., Fassnacht, M., & Murad, M. H. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0297 · Cited by 144 · cited 4×
“Right 81 (38) 48 (40) 33 (34) Left 96 (44) 55 (47) 41 (42) Bilateral 39 (18) 15 (13) 24 (24)”
InfluentialSelf-citation
Cited by
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Self-citationEpidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study
Ebbehoj, A., Li, D., Kaur, R. J., Zhang, C., Singh, S., Li, T., Atkinson, E., Achenbach, S., Khosla, S., Arlt, W., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30314-4 · Cited by 337
Self-citationIncidentally DiscoveredAdrenal Mass
Young, W., & Bancos, I. (2023) · Adrenal Disorders · doi:10.1016/b978-0-323-79285-1.00101-1 · Cited by 304
Self-citationBancos, I., Taylor, A. E., Chortis, V., Sitch, A. J., Jenkinson, C., Davidge-Pitts, C. J., Lang, K., Tsagarakis, S., Macech, M., Riester, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30218-7 · Cited by 250
Self-citationApproach to the Patient With Adrenal Incidentaloma
Bancos, I., & Prete, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab512 · Cited by 201
Self-citation
Metadata
- Authors
- Iñiguez-Ariza, N. M., Kohlenberg, J. D., Delivanis, D. A., Hartman, R. P., Dean, D. S., Thomas, M. A., Shah, M. Z., Herndon, J., McKenzie, T. J., Arlt, W., Young, W. F., & Bancos, I.
- Venue
- Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 2
- Issue
- 1
- Pages
- 30-39
- ISSN
- 2542-4548 (ISSN-L)
- OpenAlex
- W2779456396
- Cited by
- 116
- References
- 10
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.